Pseudomonas aeruginosa is an opportunistic pathogen causing nosocomial infections in
severely ill and immunocompromised patients. Ubiquitously disseminated in the …

Pseudomonas aeruginosa is an opportunistic pathogen and the leading cause of mortality
among immunocompromised patients in clinical setups. The hallmarks of virulence in P …

Antibiotics are losing efficacy due to the rapid evolution and spread of resistance.
Treatments targeting bacterial virulence factors have been considered as alternatives …

The development of therapies that modulate or prevent pathogen virulence may be a key
strategy for circumventing antimicrobial resistance. Toward that end, we examined the …

Pseudmonas aeruginosa is a Gram-negative bacterium known to be ubiquitous and
recognized as one of the leading causes of infections such as respiratory, urinary tract …

Microorganisms are considered one of the most promising niches for prospecting,
production, and application of bioactive compounds of biotechnological interest. Among …

The antibiotic cefiderocol hijacks iron transporters to facilitate its uptake and resists β-
lactamase degradation. While effective, resistance has been detected clinically with …

Introduction: Persistent infections caused by the superbug Pseudomonas aeruginosa and its
resistance to multiple antimicrobial agents are huge threats to patients with cystic fibrosis as …

The opportunistic pathogen Pseudomonas aeruginosa is a leading cause of nosocomial
infections, which are becoming increasingly difficult to treat due to antibiotic resistance …

The emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) infections
is one of the most crucial challenges currently faced by the scientific community …